Unicorn Biotechnologies

Novel. Defined. Scalable.

Founded 2020 · $3.2M raised

Employees
1–10
Founded
2020
Total Funding
$3.2M
Last Round
$3.2M SeedApr 2022
Rounds
1

About

Unicorn Biotechnologies develops compact, modular, and intelligent hardware and software infrastructure for life sciences and bioprocessing applications. The company specializes in automated cell culture platforms and bioreactor systems optimized for cultivated meat production and broader cell therapy manufacturing. Its systems provide well-characterized, high-performance cell culture environments that are novel, defined, and scalable, enabling researchers and producers to run science more efficiently and reproducibly.

Summary

Unicorn Biotechnologies is a company, founded in 2020. It has raised $3.2M in total across 1 round, most recently a $3.2M Seed round in Apr 2022. Investors include Acequia Capital, SOSV and Marinya Capital.

Tech & App Stack

4 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

Investors